Key Takeaways
- ORCL has declined for nine straight trading sessions, shedding 24% in value — marking its most prolonged downturn since late 2021
- Year-to-date losses have reached 28%, with shares now trading 57% below the all-time peak of $248.15 reached in September 2025
- Wall Street remains firmly optimistic: 84% of analysts covering the company maintain Buy ratings with a consensus target near $263.86
- Retail traders are aggressively accumulating shares — ORCL attracted more individual investor purchases than tech giants like Nvidia, Meta, Amazon, Microsoft, and Alphabet
- Market skepticism revolves around Oracle’s aggressive capital spending strategy and mounting debt obligations
When Oracle unveiled its fiscal Q4 2026 earnings on June 10, the numbers looked impressive. Revenue climbed to $19.2 billion — a robust 21% increase from the prior year — surpassing analyst expectations on both revenue and earnings. Management sweetened the outlook by lifting profit guidance. The stock market’s response? Indifference followed by relentless selling.
After reaching a 2026 peak of $248.15 on June 1, shares have declined on 18 of the subsequent 22 trading sessions. The current nine-session losing streak represents a 24% plunge — the longest consecutive decline since December 2021. From the all-time closing high established on September 10, 2025, ORCL has surrendered approximately 57% of its value.
The timing adds another layer of confusion. While Oracle continues its descent, the broader software industry has been staging a comeback. The iShares Expanded Tech-Software Sector ETF (IGV) recently completed a five-day rally, climbing more than 10% during that period. Oracle’s trajectory stands in stark contrast.
Most market observers point to financial strategy as the primary concern. The company has accumulated substantial debt to finance its ambitious AI infrastructure expansion, and shareholders appear increasingly uneasy about the pace of capital deployment and the funding mechanisms behind it.
Analyst Community Maintains Conviction
The selloff hasn’t shaken Wall Street’s confidence. Currently, 84% of analysts tracking ORCL assign it a Buy rating — a proportion that has only been exceeded once in two decades, during a brief period in May 2011.
The Street’s average price objective hovers around $263.86, suggesting potential appreciation of approximately 88% from present levels. Among the most bullish voices is Mizuho analyst Siti Panigrahi, who carries a $320 target and designates Oracle as a top recommendation, highlighting its “end to end AI stack across database, infrastructure, and applications.” Panigrahi acknowledges that financing constraints represent a meaningful risk factor, observing that Oracle will probably require external capital to support its capex roadmap.
KeyBanc analysts recently elevated their projections, expressing growing confidence that operating expense expansion will remain subdued. They’ve kept their Overweight stance with a $300 price target, emphasizing that disciplined opex management represents “where future upside will come from.”
Individual Investors Seize the Opportunity
While Wall Street watches and waits, everyday investors are taking action. According to TipRanks’ Crowd Wisdom analytics platform, which monitors portfolios from over 868,000 retail participants, ORCL experienced greater buying interest during the previous 30 days than any comparable technology stock.
Throughout the past month, 3.8% of monitored portfolios initiated or added to ORCL positions. By comparison, Microsoft attracted 3.6%, Nvidia drew 3.5%, Amazon and Alphabet each captured 2.9%, and Meta garnered 2.2%.
Among the 32 analysts who have published ratings over the last three months, 28 recommend buying while only four suggest holding — creating a Strong Buy consensus with zero Sell recommendations.
Oracle hasn’t announced its next quarterly reporting date, but the most recent Q4 release that failed to halt the stock’s decline featured $19.2 billion in revenue alongside upgraded profit expectations.



